Viewing data from:

THEOPHYLLINE

ANDA

THEOPHYLLINE | A214950 | VELZEN PHARMA PVT LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.9799

per ea

Lowest NADAC/Unit

$0.3324

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69315022701THEOPHYLLINE ER 450 MG TABLET	$0.9799	EA	Generic	—	2026-06-17
69315022601THEOPHYLLINE ER 300 MG TABLET	$0.3324	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$236.08

Highest Price

$408.04

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
69315-0226-01THEOPHYLLINE 300MG TAB,SA	$236.08	FSS	Golden State Medical Supply, Inc.	06/14/2028
69315-0227-01THEOPHYLLINE 450MG TAB,SA	$408.04	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs20 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHTHEOPHYLLINE ANHYDROUS

DMF 40971981

SHANDONG XINHUA PHARMACEUTICAL CO LTDTHEOPHYLLINE

DMF 46331982

SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHTHEOPHYLLINE HYDROUS

DMF 204552007

ALEMBIC PHARMACEUTICALS LTDTHEOPHYLLINE (ANHYDROUS) USP

DMF 353652020

DASAMI LAB PRIVATE LTDTHEOPHYLLINE ANHYDROUS USP

DMF 413192025

CONCORD LABORATORIES INCInactiveTHEOPHYLLINE CAPS., 250MG

DMF 27301976

CONCORD LABORATORIES INCInactiveTHEOPHYLLINE CAP

DMF 30401977

CORD LABORATORIES INC DIV SJ TUTAG AND COInactiveTHEOPHYLLINE CAPSULES, T.D.

DMF 31501978

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE SUSTAINED RELEASE CAPSULES, 125 MG.

DMF 31621978

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE S.R. CAPSULES, 250 MG.

DMF 31631978

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE S.R. CAPSULES 125MG

DMF 32471978

CONCORD LABORATORIES INCInactiveTHEOPHYLLINE S.R. CAPS 300MG

DMF 36581979

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE SR62.5MG MNFG IN ST.LOUIS,MO FOR SCHERING,KENILWORTH N.J.

DMF 37071980

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveTHEOPHYLLINE, ANHYDROUS

DMF 39421980

ELAN CORP PLCInactiveTHEOPHYLLINE PHARMAZOME TM POWDER

DMF 61841986

ELAN CORP PLCInactiveTHEOPHYLLINE CONTROLLED RELEASE BEADS

DMF 63271986

ALTANA LOMBERG CHEMISCHE FABRIKInactiveTHEOPHYLLINE SUSTAINED RELEASE CAPSULES (BY-158)

DMF 68181987

ELAN PHARM RES CORPInactiveTHEOPHYLLINE CONTROLLED RELEASE BEADS

DMF 69921987

BOEHRINGER INGELHEIM PHARMA KGInactiveTHEOPHYLLINE MONOHYDRATE

DMF 73011988

ROHM PHARMA GMBHInactiveTHEOPHYLLINE R 85 D/02

DMF 73541988

DAN DONG PHARMACEUTICALSInactiveTHEOPHYLLINE

DMF 73871988

WEST GRAND CORPInactiveTHEOPHYLLINE

DMF 93871991

SHANGHAI WANDAI PHARMACEUTICAL CO LTDInactiveTHEOPHYLLINE (ANHYDROUS)

DMF 96851992

CSPC INNOVATION PHARM CO LTDInactiveTHEOPHYLLINE

DMF 224812009

HAINAN POLY PHARMACEUTICAL CO LTDInactiveTHEOPHYLLINE EXTENDED RELEASE CAPSULES

DMF 232442009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 300MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 30, 2023

No patent or exclusivity listings for this strength.

#002 — 450MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 30, 2023